Sagility India maps AI-led US ops push after 2024 BirchAI deal

Why Sagility’s AI-led shift matters now

Sagility India Ltd is positioning itself around an integrated, AI-led orchestration architecture built for the complexity of the healthcare lifecycle. The company operates as a technology-enabled business process management (BPM) provider focused exclusively on the United States healthcare industry. Its pitch is centred on using AI and technology to reshape how healthcare operations perform, while using its U.S. healthcare domain expertise and partner ecosystem to deliver end-to-end outcomes. Management commentary referenced GenAI-augmented and Agentic-AI-embedded operations as key to its market expansion efforts.

This positioning comes at a time when healthcare technology services are seeing deal activity and capability buildouts. A few days earlier, Infosys announced the acquisition of Optimum Healthcare IT, a U.S.-based healthcare IT and digital transformation solutions provider, for $165 million in an all-cash deal. While Infosys operates in IT services and consulting, and Sagility operates in healthcare BPM, both moves underline the intensity of investment being directed at U.S. healthcare operations and transformation.

Company profile and ownership background

Sagility India Ltd, formerly known as Bermen India Pvt. Ltd., is a specialised BPM company focused on the healthcare sector. It provides technology-enabled services primarily to U.S.-based clients across payer (insurers) and provider (hospitals and physicians) segments. The operations originated from the healthcare division of Hinduja Global Solutions (HGS). They were acquired by Baring Private Equity Asia in 2021 and rebranded to Sagility in 2022.

Headquartered in Bengaluru, Sagility is positioned as an offshore delivery partner for critical healthcare processes. The company’s role aligns with a structural trend in the U.S. where healthcare systems outsource non-core functions with a focus on cost efficiency. This backdrop frames why Sagility is emphasising both operational execution and technology-led transformation.

What Sagility does for US payers and providers

Sagility’s business model is built around end-to-end services for the U.S. healthcare industry. The company’s stated services include claims processing, revenue cycle management, member enrollment, provider data management, and care management. These functions sit at the centre of how payers and providers manage large volumes of transactions, documentation, and interactions.

The company has also framed its value proposition around member and provider experience, quality of care, health equity, and cost-effective healthcare financial and clinical outcomes. In practical terms, the operating work spans high-frequency processes where workflow design, turnaround time, and error reduction can affect cost and service quality.

The AI-led orchestration message

Sagility’s stated direction is “deliberate and decisive” and built on three elements: leading with AI and technology, doubling down on deep U.S. healthcare expertise, and orchestrating partnerships for end-to-end impact. The company has described an “AI-led orchestration” approach, including Agentic AI, as part of how it intends to modernise healthcare operations.

Management commentary also referenced GenAI-augmented operations and Agentic-AI-embedded operations. The core argument is that AI is not being positioned as a standalone tool, but as part of an integrated operating architecture that can be applied across the healthcare lifecycle. The narrative also links these capabilities to strategic market expansion.

AI is both opportunity and threat for the model

The company’s own framing acknowledges that artificial intelligence creates both an opportunity and a threat to a healthcare BPM model. On the opportunity side, AI and automation can improve operational efficiency, automate repetitive tasks, and strengthen the value proposition to clients. Sagility has described use cases such as automating repetitive tasks in claims processing and document handling, using predictive analytics to improve revenue cycles, and deploying conversational AI to reduce call centre loads.

At the same time, AI can be a threat to traditional BPM revenue pools because automation can reduce manual effort over time. The strategic response implied in the company’s messaging is to embed AI into operations and reposition the service around outcomes, not just headcount-linked delivery.

Recent acquisitions that add AI capabilities

Sagility has linked its recent capability expansion to acquisitions over the last two years. The company’s acquisition of BirchAI in March 2024 is a central example in the information provided. BirchAI is described as a healthcare technology company offering cloud-based generative AI technology, including GenAI call technology built by experts in transformer-based natural language processing.

Sagility stated that it expects the BirchAI acquisition to enhance Member and Provider engagement capabilities and reduce clients’ operational costs. The company also described BirchAI’s technology in terms of proprietary speech-to-text and large language models (LLMs) that integrate with Sagility’s end-to-end engagement solutions. In the acquisition announcement dated March 26, 2024, Sagility’s Group CEO Ramesh Gopalan said the deal builds on Sagility’s healthcare domain expertise and supports technology-enabled transformation of the healthcare value chain. BirchAI Cofounder and CEO Kevin Terrell said Sagility’s domain expertise and healthcare presence complement BirchAI’s generative AI solutions.

BroadPath acquisition and mid-market expansion

Sagility has also disclosed that Sagility LLC, a subsidiary, acquired Broadpath Global LLC, Broadpath LLC and BHive Holdings LLC (including its subsidiary in the Philippines), described together as BroadPath Healthcare Solutions. The company stated that the acquisition accelerates expansion into mid-market health plans. It also described the deal as supporting a drive towards a more diverse client mix and adding new capabilities to its service portfolio.

This fits with the broader message that analytics, automation, and increasingly GenAI are being used to deepen engagement with existing clients and win new clients. While no financial consideration for BroadPath was included in the provided text, the rationale presented is capability and segment expansion.

Deal activity across the sector: Infosys-Optimum Healthcare IT

The acquisition of Optimum Healthcare IT by Infosys for $165 million in an all-cash deal adds context to how competitive U.S. healthcare transformation work has become. Optimum Healthcare IT provides consulting, implementation, and managed services for hospitals, health systems, and payers. The deal highlights continued demand for operational and digital transformation capabilities in healthcare, spanning both IT-led implementations and operations-led execution.

For investors tracking India-listed technology and services firms with U.S. healthcare exposure, this deal environment reinforces the importance of differentiated capabilities, including domain depth and technology integration.

Key facts and disclosed figures

Market impact: what changes operationally

The clearest operational implication of the AI-led approach is how Sagility intends to deliver healthcare processes such as claims and revenue cycle work. If repetitive tasks shift to automation, the remaining value moves toward orchestration, exception handling, compliance-focused workflows, and measurable service outcomes. The BirchAI acquisition also points to a focus on real-time customer support for complex healthcare transactions, which ties directly to member and provider engagement.

The BroadPath acquisition adds a segment angle, with mid-market health plans explicitly referenced as a target. That can matter for client concentration and growth mix, because mid-market plans often need scaled operational support but may not build the same internal technology stacks as the largest payers.

Analysis: why the strategy is structured around “orchestration”

Sagility’s use of the term “orchestration” signals an intent to integrate tools, workflows, and partnerships rather than offer point solutions. In healthcare operations, the same transaction can touch multiple systems, involve compliance checks, require accurate documentation, and trigger member or provider communication. An AI-led orchestration architecture is positioned as a way to manage that complexity across an end-to-end lifecycle.

The strategy also attempts to answer a structural question for BPM companies: how to remain relevant as automation increases. By embedding GenAI and Agentic AI into workflows, the company is signalling that it wants to capture value from transformation and productivity, not only from processing volumes.

Conclusion

Sagility India’s current narrative ties together U.S. healthcare domain depth, AI-led orchestration, and acquisitions such as BirchAI and BroadPath to expand capabilities and client segments. The disclosed Offer for Sale of Rs. 2106 cr clarifies that the company will not receive proceeds, with selling shareholders entitled to their portion. As deal activity continues in the sector, including Infosys buying Optimum Healthcare IT for $165 million, investors are likely to watch how quickly AI-embedded operations translate into deeper client engagement and measurable operational outcomes.